The leading location for therapeutic innovation

An ideal environment for growth within a supportive and networked community

History

Stevenage Bioscience Catalyst was formed through a collaboration between the Department for Business, Energy and Industrial Strategy (BEIS), GlaxoSmithKline, Wellcome and Innovate UK.

This has created a globally recognised cluster for therapeutic research and development that provides support for translation and commercialisation of innovative new medicines.

History

Stevenage Bioscience Catalyst was formed through a collaboration between the Department for Business, Energy and Industrial Strategy (BEIS), GlaxoSmithKline, Wellcome and Innovate UK.

This has created a globally recognised cluster for therapeutic research and development that provides support for translation and commercialisation of innovative new medicines.

Vision and Mission

Vision

A world class cluster of excellence that accelerates the translation of innovative science and technology to improve the health and quality of people’s lives.

Mission

To create a globally recognised vibrant life science ecosystem that brings together academics and entrepreneurs with growing and established healthcare companies in the spirit of collaboration and partnership.

Stevenage Bioscience Catalyst will achieve this by providing networks, support and expertise to enable them to connect, grow and succeed in the development and commercialisation of life changing interventions.

Vision and Mission

Vision

A world class cluster of excellence that accelerates the translation of innovative science and technology to improve the health and quality of people’s lives.

Mission

To create a globally recognised vibrant life science ecosystem that brings together academics and entrepreneurs with growing and established healthcare companies in the spirit of collaboration and partnership.

Stevenage Bioscience Catalyst will achieve this by providing networks, support and expertise to enable them to connect, grow and succeed in the development and commercialisation of life changing interventions.

Pedro Correa de Sampaio

The SBC team have been instrumental, not just in infrastructure access but in fostering a network of founders and investors. If you’ve got an idea, and you’re looking for a place to be, come to Stevenage.

Pedro Correa de Sampaio PhD, Neobe Therapeutics, CEO and Co-founder

Pedro Correa de Sampaio PhD CEO and CO Founder of Neobe Therapeutics

The SBC team have been instrumental, not just in infrastructure access but in fostering a network of founders and investors. If you’ve got an idea, and you’re looking for a place to be, come to Stevenage.

Pedro Correa de Sampaio PhD, Neobe Therapeutics, CEO and Co-founder

Governance

Stevenage Bioscience Catalyst is a Company limited by guarantee by its two
Members GSK and Wellcome. Governance of the company is directed and
controlled through the Board, Audit & Risk and Remuneration Committees.

Getting here

Stevenage Bioscience Catalyst